TVTX (Travere Therapeutics, Inc.) operates in the Health technology sector. It's currently trading at $56.59. Our composite momentum score rates it 55/110 based on price +1.4% (1d) — modest gain, rsi 71.0 — overbought, roc9 +17.2% — sharp acceleration, macd 2.83 — strong bullish crossover, beta 2.23 — high beta, and analyst: strong buy. Up 4.5% across 8 tracked price points, from Jul 7, 2026 to Jul 13, 2026.